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Objective. We studied the clinicopathological parameters of adenocarcinoma arising from endocervix (ECA) and from
endometrium (EMA) based on the expression of P16ink4a, P21waf1, and p27Kip1 proteins. Study Design. Immunohistochemistry
was done on sections of confirmed ECA and EMA from hysterectomy specimens which have had no prior chemother-
apy/radiotherapy. Results. There were 40 ECAs and 92 EMAs. The mean age of ECA was 49.82 (SD 10.29); the youngest was
30 years old and the oldest 75 years old. The mean age of EMA was 54.45 (SD 10.92); the youngest was 30 years old and the oldest
was 82 years old. For ECA, the size of the tumour is significantly associated with age and with depth of infiltration. FIGO stage
is associated with histological grade. p21WAF1 expression is significantly associated with infiltration of the corpus and lymph
node metastasis. p27Kip1 expression is significantly associated with lymph node invasion. The presence of lymph node metastasis
is strongly associated when p16INK4a and p27Kip1 expressions are analyzed in combination. For EMA, p16INK4a expression is
associated with histologic grade. Conclusion. Our study shows that we could use these cell cycle markers as predictors for more
aggressive subsets of adenocarcinoma of the cervix and endometrium.
1. Introduction
The trend of adenocarcinoma of the cervix (ECA) is increas-
ing [1–3] particularly among younger women [4]. Adenocar-
cinoma of the endometrium on the other hand aﬀect older
women, in the fifth to six decade [5]. In routine clinical prac-
tice, the presentation of these two cancers often overlap [6]
and each requires diﬀerent management [7]. ECA has more
risk of recurrence [8] than endometrial adenocarcinoma. In
Malaysia, adenocarcinoma of the cervix accounts for 5–15%
of the total cervical cancers and the trend is also increasing
[9]. The histological appearance of these two cancers under
routine H/E staining is almost similar in many instances. In a
study on fractional curettage specimens from fifteen women
who had tumours in the endocervical and endometrial speci-
mens, only 34.1%were diagnosed as endometrial carcinomas
[10]. Carcinoembryonic antigen (CEA), estrogen receptor
(ER), vimentin, and a panel of histochemical stains [11] are
routinely used to diﬀerentiate these two cancers [12, 13].
Routine IHC studies may not be helpful for synchronous
endometrial and endocervical tumors [14]. In such, clonality
studies using robust molecular techniques may help diagnose
cases in which conventional imunohistochemical studies are
not helpful [14].
p16INK4A is a molecular biomarker that consistently
discriminates uterine cervix adenocarcinoma from endome-
trial adenocarcinoma [15]. It is a cell cycle regulatory tum-
our suppressor gene that has intimate interplay with the
retinoblastoma gene [16]. p16INK4A could diﬀerentiate sim-
ilar skin conditions: actinic keratosis from Bowens disease
of which diﬀerentiating them before definitive treatment is
important as each has diﬀerent management [16]. p21WAF1
is a cyclin-dependent kinase inhibitor which acts as both a
sensor and an eﬀector of multiple antiproliferative signals
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[17]. p27Kip1 is a negative regulator of the G1 phase of the
cell cycle [18]. Attempts at diﬀerentiating the clinicopatho-
logical parameters of adenocarcinoma of the cervix from en-
dometrium have been done by a number of researchers us-
ing immunohistochemical stains [13, 14] and molecular
techniques such as Western blotting [19] and PCR [20, 21].
Among the parameters studied was presence of estrogen re-
ceptor status [19, 22].
We studied the clinical parameters of adenocarcinomas
arising from endocervix based on the expression of P16ink4a,
P21waf1, and p27Kip1 proteins and whether the presence/
absence of such protein expression correlate with clinical
presentations/behaviour of these cancers.
2. Methodology
This is a retrospective study on archived tissue blocks of his-
tologically confirmed adenocarcinoma of the cervix and en-
dometrium diagnosed from 2005 to 2008. The samples were
hysterectomy specimens with or without removal of ovaries
and fallopian tubes. Biopsies (either colposcopic or by cu-
rettage) were excluded. Specimens from patients who have
had chemotherapy or radiotherapy before hysterectomy were
excluded. These samples were taken from two public hos-
pitals located in two diﬀerent localities: Hospital Universiti
Sains Malaysia (HUSM) (north-eastern region) and Hospital
Sultanah Bahiyah (HSB) (north-western region of Malaysia).
The demography and the clinical details were obtained
from the case folders. The histological diagnoses of ECA and
EMAwere categorized according to themain histological fea-
ture as endocervical NOS, adenosquamous, endometrioid,
serous, and clear cell. The cancers are called “mixed” when
the histological findings show more than one histologi-
cal patterns. Immunohistochemistry staining was done on
4 micron thickness sections from paraﬃn blocks using
the standard immunohistochemical staining technique.
p16INK4a, P21WAF1, and P27Kip1 primary antibodies were
at 1 : 100 dilutions. Positive controls were squamous cell car-
cinoma for p16INK4a, colonic adenocarcinoma for p21KIP1,
and normal prostatic tissue for p27Kip1 tissue as per sugges-
tion by manufacturers of these antibodies. The association
was determined using multiple logistic regression tests. The
results were analysed using SPSS version 16, and the level of
confidence (P value) was set at 0.05.
The study was approved by the Research Ethics Commit-
tee of Universiti Sains Malaysia.
3. Results
There were 40 adenocarcinomas (ECAs) of the endocervix
and 92 adenocarcinomas of the endometrium (EMAs). The
median age for adenocarcinoma of the cervix was 48.5 years,
and the mean age was 49.82 (SD 10.3). The youngest patient
was 30 years old and the oldest 75 year old. The median age
for adenocarcinoma of the endometrium was 55.0 years and
the mean age was 54.45 (SD 10.9). The youngest patient was
30 years old and the oldest 82 years old. For adenocarcinoma
of the cervix, there were 74% Malays, 18% Chinese, 8%
Table 1: Summary of the clinicopathological parameters in adeno-
carcinoma of the cervix (ECA) and adenocarcinoma of the endo-
metrium (EMA).
Variables of ECA
Frequency
(%) of
ECA
Variables of EMA
Frequency
(%) of
EMA
Age (years) Age (years)
<35 3 (7.5) <50 28 (30.4)
35–54 22 (55.0) 50–60 35 (38.0)
≥55 15 (37.5) >60 29 (31.5)
FIGO stage FIGO stage
I 27 (57.5) I 50 (54.3)
ll 7 (17.5) II 13 (14.1)
lll 5 ((12.5) lll 13 (14.1)
IV 5 (12.5) lV 16 (17.4)
Histology tumor
diﬀerentiation
Myometrial
invasion
Well/moderate 25 (62.5) < 1/2 45 (48.9)
Poor and Special type 15 (37.5) > 1/2 47 (51.1)
Infiltration depth Histologic grade
Inner 2/3 13 (32.5) G1 39 (42.4)
Outer 1/3 or through 27 (67.5) G2 23 (25.0)
G3 30 (32.6)
Tumor length
Postmenopausal
status
<20mm 11 (32.5) Yes 54 (58.7)
>20mm 29 (67.5) No 38 (41.3)
Tumor thickness
<5mm 4 (10.0)
>5mm 36 (90.0)
Infiltration to corpus
Yes 17 (42.5)
No 23 (57.5)
Vascular invasion
Yes 20 (50.0)
No 20 (50.0)
Lymph node invasion
Yes 12 (30.0)
No 28 (70.0)
Histologic type: Histologic type:
Endocervical NOS 25 (62.5) Endometrioid 75 (81.5)
Adenosquamous 6 (15.0) Adenosquamous 4 (4.4)
Endometrioid 5 (12.5) Clear cell 5 (5.4)
Serous 1 (2.5) Serous 5 (5.4)
“Mixed” 2 (5.0) “Mixed” 3 (3.3)
Siamese, and no Indian patients while for endometrial
carcinoma, there were 79%Malays, 11%Chinese, 9% Indian,
and 1% Siamese ethnic group.
The most common histological type of adenocarci-
noma of the cervix was mucinous type: 62.5% (25/40),
and the commonest histological subtype of endometrial
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Table 2: Interrelationship∗ between clinicopathologic parameters in patients with adenocarcinoma of the cervix (ECA).
Age
group
(P value)
Ethnic
(P value)
Diagnosis
(P value)
Histo
grade
(P value)
FIGO
stage
(P value)
Infiltration
depth
(P value)
Tumour
size
(diameter)
(P value)
Tumor
thickness
(P value)
Corpus
infiltra-
tion
(P value)
Vascular
invasion
(P value)
LN
invasion
(P value)
Age group — 0.140 0.377 0.372 0.582 0.392 0.006 0.364 0.301 0.165 0.056
Ethnic — 0.090 0.850 0.206 0.559 0.838 0.224 0.858 0.140 0.017
Histologic type — <0.0001 0.572 0.191 0.411 0.586 0.804 0.744 0.722
Histologic grade — 0.090 0.542 0.120 0.586 0.680 0.102 0.012
FIGO stage — 0.330 0.152 1.000 0.042 0.003 <0.0001
Infiltration depth — 0.010 0.056 0.085 0.018 0.507
Tumor length — 0.025 0.230 0.013 0.076
Tumor thickness — 0.749 0.292 0.818
Corpus infiltration — 0.337 0.043
Vascular invasion — 0.038
LN invasion —
∗
Calculated using Chi-square.
Table 3: Interrelationship∗ between clinicopathological parameters in patients with adenocarcinoma of endometrium (EMA).
Age group
(P value)
Menopausal
status
(P value)
Ethnic
(P value)
Diagnosis
(P value)
Histology
grade
(P value)
Myometrial
invasion
(P value)
FIGO stage
(P value)
Age group — <0.0001 0.139 0.178 0.175 0.101 0.343
Meno status — — 0.194 0.270 0.641 0.062 0.260
Ethnic — — — 0.825 0.703 0.248 0.026
Histologic type — — — — <0.0001 0.213 0.081
Histologic grade — — — — — 0.060 <0.0001
Myometrial invasion — — — — — — <0.0001
FIGO stage — — — — — — —
∗
Calculated using Chi-square.
adenocarcinoma was endometrioid type (75/92). Majority of
the patients were in FIGO stage I (ECA 57.5%, EMA 54.3%).
The summary of the clinicopathological findings of the 132
cancers is in Table 1.
The interrelationship between the various clinicopatho-
logical correlations is as shown in Table 2 for ECA and Table
3 for EMA. For adenocarcinoma of the cervix, the grade was
significantly associated with histologic type and with lymph
node. The age of the patients was significantly associated with
the size of the tumor. The tumor size is also associated with
the depth of infiltration. FIGO stage is strongly associated
with vascular and lymph node invasion (Table 2). For ad-
enocarcinoma of the endometrium, FIGO stage is associated
with histological grade and expectedly with myometrial
invasion (Table 3).
For adenocarcinoma of the cervix, none of the clin-
icopathological parameters is significantly associated with
p16INK4a expression (Table 4) including the histologic sub-
types. p21WAF1 expression (Table 5) is significantly associ-
ated with infiltration of the corpus (P = 0.043) and lymph
node metastasis (P = 0.071), and p27Kip1 expression (Table
6) is significantly associated with lymph node invasion (P =
0.030). The presence of lymph node metastasis is strongly
associated (P = 0.013) when p16INK4a and p27Kip1 expres-
sions are analyzed in combination.
For adenocarcinoma of the endometrium, p16INK4a
expression (Table 7) is associated with histologic grade (P =
0.014) but not the histologic type (P = 0.888). p21WAF1
and p27Kip1 did not show significant associations with clin-
icopathologic parameters (P > 0.05).
4. Discussion
Adenocarcinoma arising from the cervix and the endome-
trium in our series shows overlapping clinicopathological
presentations. The youngest patients for both cancers were
30 years of age though the mean age of endocervical adeno-
carcinoma is about five years younger. There was a number
of adenocarcinomas of the cervix which was in the mean
age of adenocarcinoma of endometrium. These two cancers
also have similar ethnic distribution. The ethnic distribution
of our cases is comparable with the background population
implying fair representation of the sampling population.
They are more seen among the ethnic Malay than other eth-
nic groups in this series depicting the ethnic distributions of
the community served by the two hospitals.
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Table 4: Associations between p16INK4a expression and clinico-
pathologic parameter for endocervical adenocarcinoma.
Characteristics
No. of
patients
Positive,
n (%)
(n = 32)
Negative,
n (%)
(n = 8)
P value
Age (years)
<35 3 2 (66.7) 1 (33.3)
0.25635–54 22 16 (72.7) 6 (27.3)
≥55 15 14 (93.3) 1 (6.7)
FIGO stage
I-II 30 24 (80.0) 6 (20.0) 1.000
III-IV 10 8 (80.0) 2 (20.0)
Histology tumor
diﬀerentiation
Well/moderate 25 18 (72.0) 7 (28.0) 0.102
Poor 15 14 (93.3) 1 (6.7)
Infiltration depth
Inner 2/3 13 9 (69.2) 4 (30.8) 0.237
Outer 1/3 or through 27 23 (85.2) 4 (14.8)
Tumor size ([diameter)
<20mm 11 8 (72.7) 3 (27.3) 0.479
>20mm 29 24 (82.8) 5 (17.2)
Tumor thickness
<5mm 4 3 (75.0) 1 (25.0) 0.792
>5mm 36 29 (80.6) 7 (19.4)
Infiltration to corpus
Yes 17 13 (76.5) 4 (23.5) 0.631
No 23 19 (82.6) 4 (17.4)
Vascular invasion
Yes 20 17 (85.0) 3 (15.0) 0.429
No 20 15 (75.0) 5 (25.0)
Lymph node invasion
Yes 12 8 ( 66.7) 4 (33.3) 0.168
No 28 24 (85.7) 4 (14.3)
Histologic type
Endocervical 25 20 (80.0) 5 (20.0) 1.000
Non endocervical 15 12 (80.0) 3 (20.0)
We noted that certain clinicopathological parameters
were significantly associated with other parameters within
the same cancer. For adenocarcinoma of the cervix, the age of
the patients was significantly associated with tumor size and
with depth of infiltration. The histologic grade was strong-
ly associated with presence of lymph node metastasis. FIGO
staging was strongly associated with presence of corpus in-
filtration, vascular invasion, and lymph node metastasis. For
adenocarcinoma of endometrium, the age of the patients was
associated with menopausal status, FIGO staging with histo-
logical grading of the cancer, and presence/absence of myom-
etrial invasion.
When these clinicopathological parameters were tested
against the expression of the three cell cycle markers, none
of the clinicopathological parameters of adenocarcinoma of
Table 5: Associations between P21waf1 expression and clinico-
pathologic parameter for adenocarcinoma of the cervix.
Characteristics
No. of
patients
Positive,
n (%)
(n = 28)
Negative,
n (%)
(n = 12)
P value
Age (years)
<35 3 2 (66.7) 1(33.3)
0.93735–54 22 15 (68.1) 7 (31.8)
≥55 15 11 (73.3) 4 (33.7)
FIGO stage
I-II 30 23 (76.7) 7 (23.3) 0.111
III-IV 10 5 (50.0) 5 (50.0)
Histology tumor
diﬀerentiation
Well/moderate 25 16 (64.0) 9 (36.0) 0.285
Poor 15 12 (80.0) 3 (20.0)
Infiltration depth
Inner 2/3 13 10 (76.9) 3 (23.1) 0.507
Outer 1/3 or through 27 18 (66.7) 9 (33.3)
Tumor length
<20mm 11 7 (63.6) 4 (36.4) 0.589
>20mm 29 21 (72.4) 8 (27.6)
Tumor thickness
<5mm 4 1 (25.0) 3 (75.0) 0.101
>5mm 36 27 (75.0) 9 (25.0)
Infiltration to corpus
Yes 17 9 (52.9) 8 (47.1) 0.043
No 23 19 (82.6) 4 (17.4)
Vascular invasion
Yes 20 15 (75.0) 5 (25.0) 0.490
No 20 13 (65.0) 7 (35.0)
Lymph node invasion
Yes 12 6 (50.0) 6 (50.0) 0.071
No 28 22 (78.6) 6 (21.4)
Histologic type
Endocervical 25 17 (68.0) 8 (32.0) 0.722
Non endocervical 15 11 (73.3) 4 (26.7)
the cervix including the histologic subtypes had signifi-
cant association with p16INK4a expression alone. However,
when p16INK4a expression and p27Kip1 expressions were
analyzed in combination, there were strong associations
with presence/absence of lymph node metastasis. p21WAF1
expression alone is significantly associated with infiltration
of the corpus and lymph node metastasis. Lymph node
involvement was also significantly associated with p27Kip1
expression. For adenocarcinoma of endometrium, only
P16INK4a expression had strong association with the his-
tologic grade. p21WAF1 and p27Kip1 expressions were not
significantly associated with any clinicopathological parame-
ters. Our study shows that we could use these cell cycle mark-
ers as predictors formore aggressive subsets of adenocarcino-
mas of the cervix and endometrium.
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Table 6: Associations between p27Kip1 expression and clinico-
pathologic parameter for endocervical adenocarcinoma.
Characteristics
No. of
patients
Positive,
n (%)
(n = 17)
Negative,
n (%)
(n = 23)
P value
Age (years)
<35 3 2 (66.7) 1 (33.3)
0.29235–54 22 7 (31.8) 15 (68.2)
≥55 15 8 (53.3) 7 (46.7)
FIGO stage
I-II 30 15 (50.0) 15 (50.0) 0.097
III-IV 10 2 (20.0) 8 (80.0)
Histology tumor
diﬀerentiation
Well/moderate 25 11 (44.0) 14 (56.0) 0.804
Poor 15 6 (40.0) 9 (60.0)
Infiltration depth
Inner 2/3 13 5 (38.5) 8 (61.5) 0.720
Outer 1/3 or through 27 12 (44.4) 15 (55.6)
Tumor length
<20mm 11 5 (45.5) 6 (54.5) 0.818
>20mm 29 12 (41.4) 17 (58.6)
Tumor thickness
<5mm 4 1 (25.0) 3 (75.0) 0.395
>5mm 36 16 (44.4) 20 (55.6)
Infiltration to corpus
Yes 17 6 (35.3) 11 (64.7) 0.428
No 23 11 (47.8) 12 (52.2)
Vascular invasion
Yes 20 7 (35.0) 13 (65.0) 0.337
No 20 10 (50.0) 10 (50.0)
Lymph node invasion
Yes 12 2 (16.7) 10 (83.3) 0.030
No 28 15 (53.6) 13 (46.4)
Histologic type
Endocervical 25 9 (36.0) 16 (64.0) 0.283
Non endocervical 15 8 (53.3) 7 (46.7)
There are a number of studies which have utilized the use
of cell cycle regulatory genes such as P16INK4a, p21WAF1,
and p27Kip1 in predicting the behavior of certain cancers
such as malignant astrocytomas [23], oral squamous cell
carcinomas [24], vulval carcinomas [25], and primary large-
cell neuroendocrine carcinoma of the parotid gland [26].
In the latter, markedly reduced expressions of p21Waf1 and
p27Kip1 were noted in the salivary gland cancer cells indicat-
ing highly aggressive biologic behavior [26]. Methylation of
p16INK4a was seen to be correlated with gender and tumor
size (P = 0.005 and P = 0.035, resp.) in colorectal carcinoma
(CRC) and could be used as a marker of poor prognosis in
CRC [27]. In 224 vulvar squamous cell carcinomas stained
with p16, p21, and p27, Knopp et al., noted a high expression
of p16 as indicator of a better prognosis in the multivariate
Table 7: Associations between P16INK4a expression and clinico-
pathologic parameter for endometrial adenocarcinoma.
Characteristics
No.
patients
Positive,
n (%)
(n = 23)
Negative,
n (%)
(n = 69)
P value
Age (years)
<50 28 5 (17.9) 23 (82.1)
0.14850–60 35 7 ( 20.0) 28 (80.0)
>60 29 11 (38.0) 18 (62.0)
FIGO stage
I 50 12 (24.0) 38 (76.0) 0.809
II–IV 42 11 (26.2) 31 (73.8)
Myometrial invasion
< 1/2 45 9 (20.0) 36 (80.0) 0.278
> 1/2 47 14 (29.8) 33 (70.2)
Histologic grade
G1-G2 62 11 (17.7) 51 (82.2) 0.014
G3 30 12 (40.0) 18 (60.0)
Postmenopausal status
Yes 54 16 (29.6) 38 (70.4) 0.222
No 38 7 (18.4) 31 (81.6)
Histologic type
Endometrioid 75 16 (21.3) 59 (78.7) 0.888
Non endometrioid 17 7 (41.2) 10 (58.8)
analysis (RR = 0.5, 95% CI = 0.2–1.0) and less risk of devel-
oping lymph node metastasis (OR = 0.3, 95% CI = 0.2–0.7)
[25]. They also noted that a high level of p21 was significantly
associated with shorter survival in patients staged FIGO I
and II (RR = 3.4, 95% CI = 1.3–9.3). We could not find any
published literature on utilizing the use of these markers on
adenocarcinoma of the cervix and endometrium
In conclusion, for adenocarcinoma of the cervix,
p21WAF1 expression is significantly associated with infil-
tration of the corpus and lymph node metastasis. p27Kip1
expression is significantly associated with lymph node inva-
sion. The presence of lymph node metastasis is strongly asso-
ciated when p16INK4a and p27Kip1 expressions are analyzed
in combination. For adenocarcinoma of the endometrium,
p16INK4a expression is associated with histologic grade but
not histologic type. Our study shows that we could use these
cell cycle markers as predictors for more aggressive subsets of
adenocarcinoma of the cervix and endometrium.
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